Bell Rock Capital’s T2 Biosystems, Inc TTOO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-68
Closed -$897K 469
2019
Q1
$897K Buy
68
+4
+6% +$68.1K 0.52% 52
2018
Q4
$971K Buy
64
+6
+10% +$141K 0.65% 41
2018
Q3
$2.18M Buy
58
+10
+21% +$329K 1.07% 25
2018
Q2
$1.86M Buy
48
+11
+30% +$417K 0.94% 33
2018
Q1
$1.2M Buy
37
+9
+32% +$242K 0.64% 47
2017
Q4
$564K Buy
28
+13
+87% +$268K 0.3% 65
2017
Q3
$304K Buy
+15
New +$279K 0.17% 95
2017
Q2
Hold
0
367

Other funds holding TTOO

Bell Rock Capital's TTOO Position: Q2 2019 in Review

Bell Rock Capital sold out of T2 Biosystems, Inc (TTOO) in Q2 2019, closing a stake of 68 shares — an estimated $897K sold.

Bell Rock Capital first reported a position in TTOO in Q3 2017 and held it in 7 quarters. The position peaked at $2.18M in Q3 2018. 63 funds tracked by Wall St. Rank hold TTOO as of Q2 2019.

  • Bell Rock Capital reported no remaining T2 Biosystems, Inc position as of Q2 2019 after selling out during the quarter.
  • Bell Rock Capital sold 68 T2 Biosystems, Inc shares in Q2 2019, an estimated $897K.
  • Bell Rock Capital first reported a position in T2 Biosystems, Inc in Q3 2017 and held it in 7 quarters.
  • Bell Rock Capital's T2 Biosystems, Inc position peaked at $2.18M in Q3 2018.
  • 63 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2019.

Based on Bell Rock Capital's 13F filing for Q2 2019, filed 31 Jul 2019.